Literature DB >> 10861467

Mutation analysis of the PTEN gene in uveal melanoma cell lines.

N C Naus, W Zuidervaart, N Rayman, R Slater, E van Drunen, B Ksander, G P Luyten, A Klein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861467     DOI: 10.1002/1097-0215(20000701)87:1<151::aid-ijc23>3.0.co;2-1

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  6 in total

Review 1.  The genetics of uveal melanoma: an emerging framework for targeted therapy.

Authors:  J William Harbour
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

Review 2.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

3.  Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype.

Authors:  Alan L Ho; Elgilda Musi; Grazia Ambrosini; Jayasree S Nair; Shyamprasad Deraje Vasudeva; Elisa de Stanchina; Gary K Schwartz
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

4.  Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.

Authors:  W Zuidervaart; F van Nieuwpoort; M Stark; R Dijkman; L Packer; A-M Borgstein; S Pavey; P van der Velden; C Out; M J Jager; N K Hayward; N A Gruis
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

5.  Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas.

Authors:  S C Edmunds; I A Cree; F Dí Nícolantonío; J L Hungerford; J S Hurren; D P Kelsell
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

6.  Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma.

Authors:  C S Vetter; W Lieb; E-B Bröcker; J C Becker
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.